Alkermes

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.

About ALKS

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. 

CEO
Richard F. Pops
CEORichard F. Pops
Employees
1,800
Employees1,800
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2011
Founded2011
Employees
1,800
Employees1,800

ALKS Key Statistics

Market cap
4.99B
Market cap4.99B
Price-Earnings ratio
14.50
Price-Earnings ratio14.50
Dividend yield
Dividend yield
Average volume
1.81M
Average volume1.81M
High today
$30.46
High today$30.46
Low today
$29.97
Low today$29.97
Open price
$30.14
Open price$30.14
Volume
1.39M
Volume1.39M
52 Week high
$36.45
52 Week high$36.45
52 Week low
$22.97
52 Week low$22.97

ALKS News

Simply Wall St 4d
Alkermes shareholders have earned a 9.3% CAGR over the last five years

When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Furthermore, you'd generally like to see the share price r...

Alkermes shareholders have earned a 9.3% CAGR over the last five years

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
31.3%
Sell
0%

People also own

Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.